Clinical Trials in San Antonio

Showing 4261-4280 of 14,633 trials

A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders

NCT04516278

The study will evaluate the safety of ophthalmic bevacizumab in subjects diagnosed with a retinal condition that would benefit from treatment with intravitreal injection of bevacizumab, including: exudative age-related macular degeneration, diabetic macular edema, or branch retinal vein occlusion.

Outlook Therapeutics, Inc.195 participantsStarted Oct 2020

Tucson, Arizona, United States • Beverly Hills, California, United States • Glendale, California, United States +17 more locations

COMPLETEDPhase 3< 1 mile

A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

NCT03834753

This research study will examine the safety and effectiveness of ONS-5010 in participants with AMD. The goal is to prevent vision loss by evaluating the effectiveness of ONS-5010 as compared with ranibizumab.

Outlook Therapeutics, Inc.228 participantsStarted Jun 2019

Tucson, Arizona, United States • Arcadia, California, United States • Beverly Hills, California, United States +47 more locations

A 3-month Study to Assess the Safety of ONS-5010 in Subjects With Visual Impairment Due to Retinal Disorders

A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD)

Find Trials by Condition in San Antonio

A Study of INCB050465 in Relapsed or Refractory Mantle Cell Lymphoma Previously Treated With or Without a Bruton's Tyrosine Kinase (BTK) Inhibitor

A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases

Molecular and Epidemiological Risk Factors in the Development of Gastric Cancer

Safety and Immunogenicity of Quadrivalent Influenza mRNA Vaccine MRT5410 in Adult Participants 18 Years of Age and Older

Identifying Predictors of Poor Health-Related Quality-of-Life Among Pediatric Hematopoietic Stem Cell Donors

Study of MK-6552 in Participants With Narcolepsy Type 1 (MK-6552-004)

Evaluation of Maralixibat in Biliary Atresia Response Post-Kasai

Safety, PK, PD, Clinical Activity of KT-333 in Adult Patients With Refractory Lymphoma, Large Granular Lymphocytic Leukemia, Solid Tumors

APR-246 & Azacitidine for the Treatment of TP53 Mutant Myelodysplastic Syndromes (MDS)

A Study of BMS-986442 With Nivolumab With or Without Chemotherapy in Solid Tumors and Non-small Cell Lung Cancer

PF-06863135 As Single Agent And In Combination With Immunomodulatory Agents In Relapse/Refractory Multiple Myeloma

A Study of Mavacamten in Participants With HFpEF and Elevation of NT-proBNP With or Without Elevation of cTnT

EVAS2 IDE Prospective, Multicenter, Single Arm Safety and Effectiveness Confirmatory Study

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

BIOTRONIK Conduction System Pacing With the Solia Lead

Optical Coherence Tomography (OCT) Reference Data Collection Study (S-2015-3)

Study to Compare 2 Botulinum Type A Toxins in the Treatment of Glabellar Frown Lines

A Study of JR-171 in Patients With Mucopolysaccharidosis I